First Line Therapy for Patients With Metastatic Breast Cancer

NCT00456846 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
123
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene